Changes in the natural history of progressive multifocal leukoencephalopathy in HIV-negative lymphoproliferative disorders: Impact of novel therapies

American Journal of Hematology

Volumn 80, Issue 4, 2005, Pages 271-281

  García Suárez, Julio ^a   De Miguel, Dunia ^a   Krsnik, Isabel ^a   Bañas, Helena ^a   Arribas, Ignacio ^a   Burgaleta, Carmen ^a  

^a HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

Author keywords

Hematopoietic stem cell transplantation; Lymphoid neoplasms; Progressive multifocal leukoencephalopathy; Purine analogues

Indexed keywords

ALKYLATING AGENT; CD4 ANTIGEN; CIDOFOVIR; CYTARABINE; IMMUNOGLOBULIN; INTERLEUKIN 2; PURINE DERIVATIVE; RITUXIMAB; STEROID;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; B CELL LEUKEMIA; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; FEMALE; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; LYMPHOPROLIFERATIVE DISEASE; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RISK FACTOR; TIME;

ADULT; AGE FACTORS; AGED; ALKYLATING AGENTS; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; CD4 LYMPHOCYTE COUNT; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HIV; HUMANS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; PROGNOSIS; PURINES; RADIOTHERAPY; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; STEM CELL TRANSPLANTATION;

EID: 28544447603     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.20492     Document Type: Article

References (70)

1. Greenlee JE. Polyomavirus. In: Richman DD. Whitley RJ. Hayden FG, editors. Clinical virology. New York: Churchill Livingstone; 1997. p 549-567.
2. Astrom KE, Mancall EL, Richardson EP Jr. Progressive multifocal leuko-encephalopathy; a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin's disease. Brain 1958;81:93-111.
3. th edition. New York: Churchill Livingstone; 2000. p 1645-1651.
4. Berger JR, Concha M. Progressive multifocal leukoencephalopathy: the evolution of a disease once considered rare. J Neurovirol 1995;1:5-18.
5. Major EO, Aniemiya K, Tornatore CS, Houff SA, Berger JR. Pathogenesis and molecular biology of progressive multifoeal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev 1992;5:49-73.
6. rd edition. New York: Churchill Livingstone; 2000. p 1293-1339.
7. Anaissie EJ, Kontoyiannis DP, O'Bricn S, et al. Infections in patients with chronic lymphocytic leukemia treated with fludarabine. Ann Intern Med 1998;129:559-566.
8. Sica S, Salutari P, La Barbera EO, Sora F, Piccirillo N, Leone G. Infectious complications after CD34-selected autologous peripheral blood stem cell transplantation. Br J Haematol 1998;101: 592-593.
9. Horwitz SM, Breslin S, Negrin RS. Adjuvant rituximab after autologous peripheral blood stem cell transplant results in delayed immune reconstitution with increase in infectious complications. Blood 2000;96:707a [abstract].
10. Nie HH, Hadlai H, Jenkins JG, Steinbrenner K, Bent DH. SPSS (Statistical Package for the Social Sciences). New York, NY: McGraw-Hill; 1979.
11. Richardson EP. Progressive multifocal leukoencephalopathy. N Engl J Med 1961;265:815-823.
12. Dolman CL, Cairns AR. Leukoencephalopathy associated with Hodgkin's disease. Neurology 1961;11:349-353.
13. Deep WD, Fraumeni JF, Tashtma CK, McDivitt R. Leukoencephalopathy and dermatomyositis in Hodgkin's disease. A case report. Arch Intern Med 1964;113;635-640.
14. Castaigne P, Buge A, Escourolle R, Berger B. Progressive multifocal leukoencephalopathy with cortical lesions associated with a Hodgkin's sarcoma [in French]. Rev Neurol (Paris) 1965;112: 143-146.
15. DelDuca V Jr, Morningstar WA. Multiple myeloma associated with progressive multifocal leukoencephalopathy. JAMA 1967;199: 671-673.
16. Woodhouse MA, Dayan AD, Burston J, et al. Progressive multifocal leukoencephalopathy: electron microscope study of four cases. Brain 1967;90:863-870.
17. Rausing A, Axelsson U. Progressive multifocal leukoencephalopathy in chronic lymphatic leukaemia caused by polyoma virus? Scand J Haematol 1970;7:184-194.
18. Caldwell I, Dayan AD. Mycosis fungoides and progressive multifocal leukoencephalopathy. Br J Dermatol 1970;82:176-181.
19. Padgett BL, Walker DL. Zu Rhein GM. Eckroade RJ. Dessel BH. Cultivation of papova-like virus from human brain with progressive multifocal leucoenccphalopathy. Lancet 1971:I;1257-1260.
20. Narayan O, Penney JB Jr, Johnson RT, Herndon RM, Weiner LP. Etiology of progressive multifocal leukoencephalopathy. Identification of papovavirus. N Engl J Med 1973;289:1278-1282.
21. Ho K, Garancis JC, Paegle RD, Gerber MA, Borkowski WJ. Progressive multifocal leukoencephalopathy and malignant lymphoma of the brain in a patient with immunosuppressive therapy. Acta Neuropathol (Berlin) 1980;52:81-83.
22. Zachoval R, Hunstein W, Ho AD. Progressive multifocal leukoencephalopathy in a patient with Hodgkin's disease. Blut 1980;41:451-454.
23. Peters AC, Versteeg J, Bots GT, Boogerd W, Vielvoyc GJ. Progressive multifocal leukoencephalopathy: immunofluorescent demonstration of simian virus 40 antigen in CSF cells and response to cytarabine therapy. Arch Neurol 1980;37:497-501.
24. Bjerrum OW, Hansen OE. Progressive multifocal leucoencephalopathy in Hodgkin's disease. Scand J Haematol 1985;34:442-445.
25. Suhrland MJ, Koslow M, Perchick A, et al. Cytologic findings in progressive multifocal leukoencephalopathy. Report of two cases. Acta Cytol 1987;31:505-511.
26. McNally PG, Taylor JM, Wood JK. Progressive multifocal leucoencephalopathy associated with chronic lymphocytic leukaemia. Clin Lab Haematol 1988;10:229-233.
27. Williamson PJ, Allan NC, McIntyre MA. Cerebral Hodgkin's disease and progressive multifocal leucoencephalopathy. Clin Lab Haematol 1989;11:281-285.
28. O'Riordan T, Daly PA, Hutchinson M, Shallock AG, Gardner SD. Progressive multifocal leukoencephalopathy-remission with cytarabine. J Infect 1990;20:51-54.
29. Mesquita R, Parravicini C, Bjorkholm M, Ekman M, Biberfeld P. Macrophage association of polyomavirus in progressive multifocal leukoencephalopathy: an immunohistochemical and ultrastructural study. Case report. APMIS 1992;100:993-1000.
30. Zabernigg A, Maier H, Thaler J, Gattringer C, Late-onset fatal neurological toxicity of fludarabine. Lancet 1994;344:1780.
31. Przepiorka D, Jaeckle KA, Birdwell RR, et al. Successful treatment of progressive multifocal leukoencephalopathy with low-dose interleukin-2. Bone Marrow Transplant 1997;20:983-987.
32. Philippeau F, Honnorat J, Nighoghossian N, et al. JC virus infection and lympho-plasmocytic infiltration of the central nervous system revealed by a cerebellar syndrome [in French]. Rev Neurol (Paris) 1999;155:961-965.
33. Gonzalez H, Bolgert F, Camporo P, Leblond V. Progressive multifocal leukoencephalitis (PML) in three patients treated with standard-dose fludarabine (FAMP). Hematol Cell Ther 1999;41:183-186.
34. Re D, Bamborschke S, Feiden W, et al. Progressive multifocal leukoencephalopathy after autologous bone marrow transplantation and alpha-interferon immunotherapy. Bone Marrow Transplant 1999;23:295-298.
35. Cid J, Revilla M, Cervera A, et al. Progressive multifocal leukoencephalopathy following oral fludarabine treatment of chronic lymphocytic leukemia. Ann Hematol 2000;79:392-395.
36. Saad ED, Thomas DA, O'Brien S, et al. Progressive multifocal leukoencephalopathy with concurrent Richter's syndrome. Leuk Lymphoma 2000;38:183-190.
37. Mata MI, Gardella S, del Mar Castellanos M, Ortiz MR. Progressive multifocal leukoencephalopathy in a patient with chronic lymphatic leukemia treated with fludarabine [in Spanish]. Med Clin (Barc) 2000;115:598-599.
38. Daibata M, Hatakeyama N. Kamioka M, et al. Detection of human herpesvirus 6 and JC virus in progressive multifocal leukoencephalopathy complicating follicular lymphoma. Am J Hematol 2001;67:200-205.
39. Vidarsson B, Mosher DF, Salamat MS, Isaksson HJ, Onundarson PT. Progressive multifocal leukoencephalopathy after fludarabine therapy for low-grade lymphoproliferativc disease. Am J Hematol 2002;70:51-54.
40. Saumoy M, Castells G, Escoda L, Mares R, Richart C, Ugarriza A. Progressive multifocal leukoencephalopathy in chronic lymphocytic leukemia after treatment with fludarabine. Leuk Lymphoma 2002;43:433-436.
41. Rodriguez L, Ribera JM, Batlle M, et al. Progressive multifocal leukoencephalopathy shortly after the diagnosis of follicular lymphoma in a patient treated with fludarabine. Haematologica 2002;87:ECR26.
42. Leonard S, Hulin C, Anxionnat R, Grignon Y, Taillandier L, Vespignani H. Multifocal progressive leukoencephalitis in a patient given fludarabine for chronic lymphoid leukemia [in French]. Rev Neurol (Paris) 2002;158:1121-1123.
43. Osorio S, de la Camara R, Golbano N, et al. Progressive multifocal leukoencephalopathy alter stem cell transplantation, unsuccessfully treated with cidofovir. Bone Marrow Transplant 2002;30:963-966.
44. Goldberg SL, Pecora AL, Alter RS, et al. Unusual viral infections (progressive multifocal leukoencephalopathy and cytomegalovirus disease) after high-dose chemotherapy with autologous blood stem cell rescue and peritransplantation rituximab. Blood 2002;99: 1486-1488.
45. Matteucci P, Magni M, Di Nicola M, Carlo-Stella C, Uberti C, Gianni AM. Leukoencephalopathy and papovavirus infection after treatment with chemotherapy and anti-CD20 monoclonal antibody. Blood 2002;100:1104-1105.
46. Ng C, Slavin MA, Seymour JF. Progressive multifocal leukoencephalopathy complicating Waldenström's macroglobulinaemia. Leuk Lymphoma 2003;44:1819-1821.
47. Montillo M, Tedeschi A, O'Brien S, et al. Phase 11 study of cladribine and cyclophosphamide in patients with chronic lymphocytic leukemia and prolymphocytic leukemia. Cancer 2003;97: 114-120.
48. Kiewe P. Scyfert S, Korper S, Rieger K, Thiel E, Knauf W. Progressive multifocal leukoencephalopathy with detection of JC virus in a patient with chronic lymphocytic leukemia parallel to onset of fludarabine therapy. Leuk Lymphoma 2003;44:1815-1818.
49. Steurer M, Clausen J, Gotwald T, et al. Progressive multifocal leukoencephalopathy after allogeneic stem cell transplantation and posttransplantation rituximab. Transplantation 2003;76;435-436.
50. Bower JH, Hammack JE, McDonnell SK, Tefferi A. The neurologic complications of B-cell chronic lymphocytic leukemia. Neurology 1997;48:407-412.
51. d'Arminio Monforte A. Cinque P. Vago L, et al. A comparison of brain biopsy and CSF-PCR in the diagnosis of CNS lesions in AIDS patients. J Neurol 1997;244:35-39.
52. Grcenlee JE. Progressive multifocal leukoencephalopathy-progress made and lessons relearned. N Engl J Med 1998;338:1378-1380.
53. Diehl V, Stein H, Hummel M, Zollinger R, Connors JM. Hodgkin's lymphoma: biology and treatment strategies for primary, refractory, and relapsed disease. Hematology (Am Soc Hematol Educ Prog) 2003;225-247.
54. Wijermans PW, Gerrits WB, Haak HL. Severe immunodeficiency in patients treated with fludarabine monophosphate. Eur J Haematol 1993;50:292-296.
55. Albrecht H, Hoffmann C, Degen O, et al. Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy. AIDS 1998;12:1149-1154.
56. Gasnault J, Kousignian P, Kahraman M, et al. Cidofovir in AlDS-associated progressive multifocal leukoencephalopathy: a monocenter observational study with clinic and JC virus load monitoring. J Neurovirol 2001;7:375-381.
57. rd edition. New York: Churchill Livingstone; 2000. p 1350-1363.
58. Steingrimsdottir H, Gruber A, Bjorkholm M, Svensson A, Hansson M. Immune reconstitution after autologous hematopoietic stem cell transplantation in relation to underlying disease, type of high-dose therapy and infectious complications. Haematologica 2000;85:832-838.
59. + -enrichcd versus non-T cell-depleted autologous peripheral blood stem cell transplantation. J Hematother Stem Cell Res 2000;9:727-736.
60. Flohr T, Hess GR, Kreiter S, Meyer RG, Huber C, Derigs G. Immune reconstitution after autologous CD34-positive selected peripheral blood stem cell transplantation combined with rituximab for refractory B-ecll non-Hodgkin's lymphoma. Blood 2000;96:709a [abstract].
61. Sabath BF, Major EO. Traffic of JC virus from sites of initial infection to the brain: the path to progressive multifocal leukoencephalopathy. J Infect Dis 2002;186(Suppl 2):S180-S186.
62. Fong IW, Toma E. The natural history of progressive multifocal leukoencephalopathy in patients with AIDS. Canadian PML Study Group. Clin Infect Dis 1995;20:1305-1310.
63. Berenguer J, Miralles P, Arrizabalaga J, et al. Clinical course and prognostic factors of progressive multifocal leukoencephalopathy in patients treated with highly active antiretroviral therapy. Clin Infect Dis 2003;36:1047-1052.
64. Thurnher MM, Post MJ, Rieger A, Kleibl-Popov C, Loewe C, Schindler E. Initial and follow-up MR imaging findings in AIDS-related progressive multifocal leukoencephalopathy treated with highly active antiretroviral therapy. Am J Neuroradiol 2001;22: 977-984.
65. Segarra-Newnham M, Vodolo KM. Use of cidofovir in progressive multifocal leukoencephalopathy. Ann Pharmacother 2001;35:741-744.
66. Koralnik IJ. New insights into progressive multifocal leukoencephalopathy. Curr Opin Neurol 2004;17:365-370.
67. Weber F, Goldmann C, Kramer M, et al. Cellular and humoral immune response in progressive multifocal leukoencephalopathy. Ann Neurol 2001;49:636-642.
68. Du Pasquier RA, Kuroda MJ. Zheng Y, Jean-Jacques J, Letvin NL, Koralnik IJ. A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy. Brain 2004;127:1970-1978.
69. Ljungman P. Prevention and treatment of viral infections in stem cell transplant recipients. Br J Haematol 2002;118:44-57.
70. Elphick GF, Querbes W, Jordan JA, et al. The human polyomavirus, JCV, uses serotonin receptors to infect cells. Science 2004; 306:1380-1383.